AI / ML INNOVATIONS INC - AIMLF STOCK NEWS

Welcome to our dedicated page for AI / ML INNOVATIONS news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML INNOVATIONS stock.

AI/ML Innovations Inc. (AIMLF) is a pioneering company in the artificial intelligence (AI) and machine learning (ML) sectors, dedicated to acquiring and advancing technologies that address critical societal needs. Established to capitalize on the burgeoning fields of AI and ML, the company focuses on emerging digital health and wellbeing solutions that leverage AI, cloud computing, and digital platforms to revolutionize healthcare management.

AI/ML Innovations Inc. is committed to transforming healthcare through strategic partnerships and innovative initiatives. Its majority-owned subsidiary, Health Gauge Inc., is at the forefront of health tech innovation. Health Gauge has developed the ‘Follow Your Heart’ smartwatch, a wellness tool that uses proprietary AI PrecisionPulse Neural Network measurement technology to provide non-invasive, medical-grade accurate blood pressure readings. This product is a significant step forward in addressing the hypertension epidemic, offering users convenient and precise health monitoring.

In addition to consumer products, AI/ML Innovations Inc. supports healthcare innovators and researchers with advanced tools like The Pulse Guru, a smart sensor wearable that offers unparalleled access to raw ECG and PPG signal data. This device is instrumental for professionals needing detailed cardiovascular insights.

The company’s strategic growth also includes a recent acquisition of Naiad Labs Inc.’s product division, integrating the Long ECG Neural Net, which drastically reduces the time needed to label long ECGs, enhancing accuracy and efficiency in cardiovascular diagnostics.

AI/ML Innovations Inc. continues to expand its technological footprint with the launch of NeuralCloud Solutions Incorporated, a subsidiary focused on merging smart sensor technology with digital health. The company aims to make high-quality personal biometric data accessible to individuals globally, supported by robust AI and neural network technologies.

AI/ML Innovations Inc. trades on the Canadian Securities Exchange under the symbol AIML, the OTCQB Venture Market under AIMLF, and the Frankfurt Stock Exchange under 42FB. For more information, visit the company's website.

12/11/2023 08:50 AM

News

AI/ML Innovations Inc. Terminates Investor Relations Appointment

Rhea-AI Summary

AI/ML Innovations Inc. (AIML) terminates Marketing Services Agreement with Octagon Media Corp and Jack Marks. CEO Paul Duffy announces arms-length funding, propelling the company into a new phase of strategic development. The company achieves all stated milestones in the First 100-Day plan and plans to share the Next 100-Day plan in early January.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

4.2%

Tags

12/08/2023 04:45 PM

News

AI/ML Innovations Inc. Enters Market Awareness Agreement

Rhea-AI Summary

AI/ML Innovations Inc. (AIML) has appointed Follow The Money Investment Group (FTMIG) as a marketing consultant to increase awareness of the company through various market communications initiatives. FTMIG will be paid $75,200 plus direct expenses from general corporate funds for a 12-month period.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

4.2%

Tags

12/07/2023 04:45 PM

News

AI/ML Innovations Inc. Announces Closing of Private Placement

Rhea-AI Summary

AI/ML Innovations Inc. (AIML) plans to close a non-brokered private placement, accepting subscriptions for 11,576,666 units at $0.06 per unit, resulting in gross proceeds of $694,599.94. Each unit consists of one common share and one common share warrant, with the intention to use the net proceeds for working capital requirements.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-4.76%

Tags

12/01/2023 05:00 PM

News

AI/ML Innovations Inc. Grants Stock Options

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) issues 1,400,000 stock options to management and consultants at $0.20 per share, with exercise periods of up to 5 years for management and 2 years for consultants.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

7.8%

Tags

11/21/2023 05:00 PM

News

AI/ML Innovations Inc. Announces Annual General Meeting Results

Rhea-AI Summary

AI/ML Innovations Inc. (AIML) successfully held its Annual General Meeting on November 17, 2023, with a 21.1% shareholder turnout. All resolutions, including the election of Directors, appointment of auditors, and approval of stock option and share unit plans, were overwhelmingly approved with over 99% of the vote. The company's commitment to acquiring and advancing AI/ML technologies for urgent societal needs is evident in its strategic decisions and shareholder support.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

11/09/2023 08:00 AM

News

AI/ML Innovations Inc.'s Subsidiary Announces Strategic Partnership with a Leader in Virtual Occupational Health Clinics

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces its minority-owned subsidiary, Tech2heal, has partnered with a leading French company in virtual occupational health clinics. The alliance aims to address mental health and sleep disorders, utilizing Tech2heal's AI-driven healthcare platform, Alakin, to provide innovative risk prevention solutions tailored to corporate clients.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.41%

Tags

11/01/2023 10:48 AM

News

AI/ML Innovations Inc., Advancing AI+AR Smart Glasses for Trillion Dollar Global Healthcare Markets

Rhea-AI Summary

AI/ML Innovations Inc. announces partnership with Essilor International to develop an Augmented Reality Eyewear platform named 'POPULAR'. The company also collaborates with Luxottica, a $78 billion eyewear giant, opening doors to opportunities in the global eyewear market. AI/ML's cohesive framework focuses on capturing, analyzing, and taking action in the cloud with the help of AI, ML, and neural nets.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-4.38%

Tags

10/24/2023 11:00 AM

News

VIDEO - AI/ML Innovations: Pioneering Innovations in AI & Healthcare CEO Clips Video

Rhea-AI Summary

AI/ML Innovations Inc. unveils groundbreaking wearable technology for healthcare, focusing on artificial intelligence and machine learning.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-7.95%

Tags

10/19/2023 07:30 AM

News

AI/ML Innovations Inc.'s Subsidiary Enters Consortium with Ellisor International for AI-powered Augmented Reality Eyewear Project

Rhea-AI Summary

Tech2heal, a subsidiary of AI/ML Innovations, joins a consortium led by Essilor International to develop an Augmented Reality Eyewear platform. Tech2heal will develop an app offering telehealth, patient monitoring, and sports applications.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

14.07%

Tags

10/18/2023 07:30 AM

News

AI/ML Innovations Inc.’s Subsidiary Chosen as the Digital Technology Provider for an International Clinical Study Funded by European Commission

Rhea-AI Summary

Tech2heal, a subsidiary of AI/ML, has secured its second clinical trial contract for a project named 'My Health Friend' that focuses on preventative healthcare. The trial aims to improve the well-being of a cross-border population through personalized digital rehabilitation.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-8.79%

Tags

FAQ

What is the current stock price of AI / ML INNOVATIONS (AIMLF)?

The current stock price of AI / ML INNOVATIONS (AIMLF) is $0.04948 as of November 14, 2024.

What is the market cap of AI / ML INNOVATIONS (AIMLF)?

The market cap of AI / ML INNOVATIONS (AIMLF) is approximately 7.0M.

What does AI/ML Innovations Inc. do?

AI/ML Innovations Inc. focuses on acquiring and advancing AI and ML technologies to address urgent societal needs, particularly in the digital health and wellness sectors.

What is 'Follow Your Heart'?

'Follow Your Heart' is a wellness smartwatch developed by Health Gauge Inc., a subsidiary of AI/ML Innovations Inc. It offers medical-grade accurate blood pressure measurements using AI PrecisionPulse Neural Network technology.

What are the key features of The Pulse Guru?

The Pulse Guru, developed by Health Gauge, provides continuous time-series data from ECG and PPG streams using proprietary AI PrecisionPulse Neural Network technology, offering deep cardiovascular insights for researchers and healthcare innovators.

What recent acquisitions has AI/ML Innovations Inc. made?

AI/ML Innovations Inc. recently acquired Naiad Labs Inc.'s product division, including the Long ECG Neural Net, which significantly reduces the time needed to label long ECGs.

What is NeuralCloud Solutions Incorporated?

NeuralCloud Solutions Incorporated is a wholly-owned subsidiary of AI/ML Innovations Inc., focused on advancing and monetizing the company’s smart sensor and digital health technologies through AI and neural networks.

How does AI/ML Innovations Inc. plan to expand its market presence?

The company aims to expand through strategic partnerships, innovative product launches, and the integration of advanced AI technologies in healthcare solutions, making biometric data accessible globally.

Where can I buy AI/ML Innovations Inc. products?

Products such as 'Follow Your Heart' are available through retail pharmacy channels and other outlets serving patients with hypertension.

What is the Neural Net Store?

The Neural Net Store is an online portal offering commercial access to AI/ML Innovations Inc.'s healthcare solutions as APIs or web applications, enabling easy integration into third-party applications.

How does AI/ML Innovations Inc. support the healthcare industry?

The company provides advanced AI-driven tools and solutions that offer precise health monitoring and insights, supporting healthcare professionals, researchers, and device developers in their work.

What is the significance of the Long ECG Neural Net?

The Long ECG Neural Net provides accurate and quick labeling of long ECGs, significantly reducing the time and effort required for cardiovascular diagnostics and research.